These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5627797)

  • 1. [Drug susceptibility of Pseudomonas bacilli in otorhinolaryngology].
    Iwasawa T
    Jibiinkoka; 1967 Nov; 39(11):1251-9. PubMed ID: 5627797
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pseudomonas pyocyanea infections in otorhinolaryngology].
    Nicoucar GR
    Pract Otorhinolaryngol (Basel); 1969; 31(6):359-64. PubMed ID: 4314671
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pseudomonas pyocyanea: in-vitro sensitivity to antibiotics].
    Cucchiara E
    G Mal Infett Parassit; 1971 Nov; 23(11):1045-7. PubMed ID: 5150979
    [No Abstract]   [Full Text] [Related]  

  • 4. [Infections caused by pyocyanic bacilli in otorhinolaryngology].
    Maduro R; Gandon J
    Probl Actuels Otorhinolaryngol; 1965; ():169-86. PubMed ID: 4964139
    [No Abstract]   [Full Text] [Related]  

  • 5. [The genetic basis of the variability of germs in otorhinolaryngologic diseases. I. The appearance of resistance to antibiotics in bacteria].
    Midan F; Lengyel Z; Dumitrescu M
    Otorinolaringologie; 1968; 13(4):315-24. PubMed ID: 5720732
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp.
    Fodor E; Hajdú E; Nagy E
    Int J Antimicrob Agents; 2005 Feb; 25(2):183-4. PubMed ID: 15664494
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy for Pseudomonas infections].
    Takayasu H; Nishiura T; Terawaki Y
    Naika; 1967 Aug; 20(2):232-7. PubMed ID: 5586774
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy for Pseudomonas infections].
    Takayasu H; Nishiura T; Terawaki Y
    Naika; 1967 Aug; 20(8):232-7. PubMed ID: 5584145
    [No Abstract]   [Full Text] [Related]  

  • 9. [The genetic basis of the variability of germs in otorhinolaryngologic diseases. II. Appearance of resistance to antibiotics due to recombinations].
    Lengyel Z; Midan F; Dumitrescu M
    Otorinolaringologie; 1968; 13(4):325-36. PubMed ID: 5720733
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of new antibiotics in the treatment of Pseudomonas infections. I. In vitro tests].
    Pérez Ureña MT; Iriarte MT; Fernández P
    Rev Clin Esp; 1969 May; 113(3):235-40. PubMed ID: 5348710
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Pseudomonas aeruginosa infection.
    Eykyn SJ
    Br J Hosp Med; 1984 Feb; 31(2):136-40. PubMed ID: 6421353
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern antibiotic therapy in otorhinolaryngology--problems and perspectives].
    Janosević L; Janosević S; Pokrajac M
    Srp Arh Celok Lek; 2002; 130 Suppl 1():44-8. PubMed ID: 12395464
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudomonas spp. and antibiotics in exacerbation of chronic obstructive pulmonary disease (COPD).
    Beghi G; Pasargiklian I; Mascheroni E; Boilini G; Scarazatti E; Lusco G
    J Chemother; 1995 Nov; 7 Suppl 4():163-4. PubMed ID: 8904143
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of infections caused by Pseudomonas aeruginosa (pyocyanosis)].
    Chernomordik AB; Panchenko MK; Bulycheva NP
    Klin Med (Mosk); 1982 Jun; 60(6):17-20. PubMed ID: 6811797
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug sensitivity of Haemophilus influenzae isolated from children with otorhinolaryngologic diseases].
    Kuklińska-Michalska D; Gutkowska J; Wójcik E; Kopacka B
    Med Dosw Mikrobiol; 1981; 33(1):39-46. PubMed ID: 6974287
    [No Abstract]   [Full Text] [Related]  

  • 16. [Active drugs against Pseudomonas aeruginosa and their clinical usefulness].
    Gobernado M
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():51-61. PubMed ID: 9844479
    [No Abstract]   [Full Text] [Related]  

  • 17. Monovalent Pseudomonas aeruginosa vaccines in the treatment of otolaryngeal infections with Pseudomonas aeruginosa.
    Cincă D; Meitert E; Tomescu E; Meitert T; Suciu M; Sima F; Savulian C; Midan F; Lică I
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):277-84. PubMed ID: 6818930
    [No Abstract]   [Full Text] [Related]  

  • 18. The control of experimental infection in mice produced by Pseudomonas pseudomallei.
    Hobby GL; Lenert TF; Maier-Engallena J; DeNola-Cicenia E
    Am Rev Respir Dis; 1969 Jun; 99(6):952-4. PubMed ID: 5787609
    [No Abstract]   [Full Text] [Related]  

  • 19. [Laboratory and clinical studies on lividomycin in otorhinolaryngology].
    Baba S; Mamiya A; Hondo J; Mitsumura Y; Wada K
    Jpn J Antibiot; 1972 Dec; 25(6):501-5. PubMed ID: 4541928
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metallo-beta-lactamases producing Pseudomonas aeruginosa in Algeria].
    Aggoune-Khinache N; Bensersa D; Henniche FZ; Daoudi M; Abdouni MA; Chabani A; Tiouit D; Naim M
    Med Mal Infect; 2009 Jun; 39(6):413-4. PubMed ID: 19111417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.